Pamicell, Foreigners Net Sell 125,000 Shares... Stock Price Down 2.89%
As of 1:31 PM on the 22nd, Pamicell is trading at 19,550 KRW, up 2.89% from the previous day. This is a decline of 18.88% compared to May 29. Pamicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners have a tentative net sell of 125,000 shares of Pamicell, and institutions have a net sell of 13,000 shares. Over the past five days, individual investors have net sold 181,314 shares, while foreigners and institutions have net bought 216,456 shares and 19,375 shares, respectively.
On June 17, Pamicell was a market issue due to the news of the weak effect of 'Dexamethasone' in treating COVID-19.
[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- Electronic Financial Services Revenue Surpasses 12 Trillion Won Last Year... Number of Non-Compliant Companies Rises to 29
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
